Literature DB >> 18658094

Evidence for endotoxin as a causative factor for leptospiral uveitis in humans.

Chidambaranathan Gowri Priya1, Sivakumar R Rathinam, Veerappan Muthukkaruppan.   

Abstract

PURPOSE: To understand the pathogenic mechanism of leptospiral uveitis by determining the profile of infiltrating cells, the levels of cytokines, and the causative factor in aqueous humor (AH).
METHODS: AH and blood samples were collected from 22 patients with leptospiral uveitis that was confirmed by microscopic agglutination test (MAT). Nine patients with Behçet's uveitis, 10 with phacolytic uveitis, and 13 with age-related cataract were included as control subjects. A cytometric bead array was used to estimate human inflammatory and Th1/Th2 cytokines. The level of endotoxin in AH was estimated by limulus amebocyte lysate (LAL) test and by dot blot analysis using a leptospiral serovar lipopolysaccharide (LPS)-specific monoclonal antibody.
RESULTS: Except for one patient with leptospiral uveitis, AH from all other patients and control subjects was negative for Gram-negative bacterial endotoxin by LAL test. However, a significant level of serovar Copenhageni LPS was observed in AH of patients with leptospiral uveitis seropositive for the same serovar by MAT, in contrast to its absence in all control subjects. A selective infiltration of neutrophils as well as a significant increase in the levels of protein and cytokines IL-12p70, TNF, IL-6, IL-8, and IL-10 was observed in AH of patients with leptospiral uveitis. Phacolytic uveitis was associated with a high proportion of activated macrophages and increased levels of IL-6 and IL-8, whereas Behçet's uveitis was associated with a predominant infiltration of neutrophils and increased levels of IFN-gamma.
CONCLUSIONS: The results demonstrate the presence of serovar-specific LPS in AH, and thus it is likely that endotoxin is a causative factor in leptospiral uveitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658094     DOI: 10.1167/iovs.08-2174

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Leptospira interrogans lpxD Homologue Is Required for Thermal Acclimatization and Virulence.

Authors:  Azad Eshghi; Jeremy Henderson; M Stephen Trent; Mathieu Picardeau
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

2.  Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways.

Authors:  Huan Wang; Yifei Wu; David M Ojcius; X Frank Yang; Chenglin Zhang; Shibiao Ding; Xu'ai Lin; Jie Yan
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

3.  Interaction between Leptospiral Lipopolysaccharide and Toll-like Receptor 2 in Pig Fibroblast Cell Line, and Inhibitory Effect of Antibody against Leptospiral Lipopolysaccharide on Interaction.

Authors:  Yijie Guo; Tomokazu Fukuda; Shuichi Nakamura; Lanlan Bai; Jun Xu; Kengo Kuroda; Rintaro Tomioka; Hiroshi Yoneyama; Emiko Isogai
Journal:  Asian-Australas J Anim Sci       Date:  2015-02       Impact factor: 2.509

4.  Inhibitory effect of BMAP-28 on Leptospiral Lipopolysaccharide-Induced TLR2-Dependent Immune Response in Bovine Cells.

Authors:  Yijie Guo; Cuiping Ding; Bo Zhang; Jun Xu; Meng Xun; Jiru Xu
Journal:  Jundishapur J Microbiol       Date:  2016-06-21       Impact factor: 0.747

5.  Leptospira and inflammation.

Authors:  C F Gonçalves-de-Albuquerque; P Burth; A R Silva; M Younes-Ibrahim; H C Castro-Faria-Neto; M V Castro-Faria
Journal:  Mediators Inflamm       Date:  2012-10-21       Impact factor: 4.711

6.  Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases.

Authors:  Martina Bonacini; Alessandra Soriano; Luca Cimino; Luca De Simone; Elena Bolletta; Fabrizio Gozzi; Francesco Muratore; Maria Nicastro; Lucia Belloni; Alessandro Zerbini; Luigi Fontana; Carlo Salvarani; Stefania Croci
Journal:  Front Immunol       Date:  2020-03-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.